Bulletin
Investor Alert

Protagonist Therapeutics Inc.

NAS: PTGX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205674595/composite

$

34.59

Change

0.00 0.00%

Volume

Volume 20,803

Jan 18, 2022, 5:02 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205674595/composite

Today's close

$ 35.96

$ 34.59

Change

-1.37 -3.81%

Day low

Day high

$34.36

$35.49

Open
Open: 34.76

52 week low

52 week high

$12.80

$50.54

Open

Market cap

$1.72B

Average volume

584,967

P/E ratio

N/A

Rev. per Employee

$308,734

EPS

-2.41

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ptgx

MarketWatch News on PTGX

  1. Protagonist Therapeutics upgraded to overweight from neutral at J.P. Morgan

    5:47 a.m. Oct. 12, 2021

    - Tomi Kilgore

  2. Protagonist Therapeutics downgraded to neutral from overweight at J.P. Morgan

    5:54 a.m. Sept. 20, 2021

    - Tomi Kilgore

  3. Biotech stocks are a buy — especially these 18 picks

    1:02 p.m. March 13, 2021

    - Michael Brush

  4. Protagonist Therapeutics initiated at overweight with $35 price target at JPMorgan

    10:01 a.m. Jan. 6, 2021

    - Tonya Garcia

  5. Protagonist Therapeutics stock price target raised to $29 vs. $13 at Instinet

    7:22 a.m. May 10, 2019

    - Ciara Linnane

  6. Protagnoist Therapeutics stock price target raised to $17 from $11 at Stifel Nicolaus

    7:16 a.m. May 9, 2019

    - Tomi Kilgore

  7. Protagonist Therapeutics upgraded to buy from hold at Stifel Nicolaus

    7:16 a.m. May 9, 2019

    - Tomi Kilgore

  8. Charting the Market

    8:02 p.m. March 30, 2018

    - Barron's Online

  9. A Biotech Collapses: Is Buying Now ‘Futile’?

    4:05 p.m. March 26, 2018

    - Barrons Blogs

  10. Protagonist Therapeutics started at buy with $32 stock price target at Stifel Nicolaus

    7:22 a.m. Jan. 29, 2018

    - Tomi Kilgore

  11. Charting the Market

    9:36 p.m. June 2, 2017

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/ptgx

Other News on PTGX

  1. 10-Q: PROTAGONIST THERAPEUTICS, INC

    4:12 p.m. Nov. 3, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  2. Wall Street Breakfast: What Moved Markets

    6:47 a.m. Oct. 16, 2021

    - Seeking Alpha

  3. New Strong Sell Stocks for October 14th

    8:27 a.m. Oct. 14, 2021

    - Zacks.com

  4. CEI, ANY and HNRG among mid-day movers

    11:42 a.m. Oct. 12, 2021

    - Seeking Alpha

  5. APRN, CEI and GOTU among mid-day movers

    11:39 a.m. Oct. 11, 2021

    - Seeking Alpha

  6. Loading more headlines...
/news/pressrelease/company/us/ptgx

Press Releases on PTGX

  1. /C O R R E C T I O N -- Protagonist Therapeutics, Inc./

    12:25 p.m. Jan. 4, 2022

    - PR Newswire - PRF

  2. Protagonist Therapeutics Reports Granting of Inducement Awards

    4:05 p.m. Sept. 15, 2021

    - PR Newswire - PRF

  3. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200030751/composite CLSK-1.06%
  • /zigman2/quotes/228559245/composite ADGI-78.81%
  • /zigman2/quotes/216531076/composite ESSC-26.63%
  • /zigman2/quotes/211617595/composite BYND+9.29%
  • /zigman2/quotes/205021014/composite RUN-15.70%
X
Powered by StockTwits
Link to MarketWatch's Slice.